Association of anti-adalimumab antibodies with ocular inflammation in the management of autoimmune diseases
Accept poster if oral is not possible ?
Yes
Purpose
This retrospective case-control study investigates the association of anti-adalimumab antibodies in individuals receiving adalimumab, comparing those with ocular inflammation to those without.
Methods
The Stanford Research Repository (STARR) database was used to identify patients treated with adalimumab for more than six months for various autoimmune disorders from June 2006 to May 2024. The data recorded included demographics, clinical diagnosis, treatment course, adalimumab, and AAA levels.
Results
A total of 720 patients taking adalimumab were included, of which 156 (21.6%) were positive for AAA (AAA+ group). Among 676 patients with systemic diseases, 74 (10.9%) had ocular inflammation. AAA positivity was significantly more prevalent among patients with ocular inflammation than those without (35.1% vs. 18.8%, p<0.01). Compared to the AAA- group, the AAA+ group had a significantly higher proportion of females (61.5% vs. 47.4%, p<0.01), ocular inflammation (27.6% vs. 13.3%, p<0.01), and IBD (40.4% vs. 67.8%, p<0.01). Multiple logistic regression analysis showed that ocular inflammation was significantly associated with the presence of AAA (adjusted OR: 2.34, 95% CI: 1.38-3.95, p<0.01), while systemic diseases did not show a significant association (adjusted OR: 0.91, 95% CI: 0.42-1.99, p=0.82).
Conclusion
Ocular inflammation, regardless of the concurrent diagnosis of systemic disease, may be associated with a higher risk of AAA in patients receiving adalimumab therapy, indicating the potential necessity for more frequent monitoring of adalimumab and AAA levels in these patients.
Conflict of interest
No
1
Last name
EL FEQI
Initials of first name(s)
D
Department
Ophthalmology
City
Palo Alto
Country
United States
2
Last name
Elaraby
Initials of first name(s)
O
Department
Ophthalmology
City
Palo Alto
Country
United States
3
Last name
Hung
Initials of first name(s)
J H
Department
Ophthalmology
City
Palo Alto
Country
United States
4
Last name
Nguyen
Initials of first name(s)
Q D
Department
Ophthalmology
City
Palo Alto
Country
United States
This website uses cookies to ensure you get the best experience on our website.
Learn more